Navigation Links
Molecular markers used for assessment of early sciatic nerve injury
Date:12/26/2013

Substance P and calcitonin gene-related peptide are the main neuropeptides in peripheral nerve ganglia, which can anterogradely transmit nociceptive information to the central nervous system. In a study by Dr. Changma Fu and co-workers from First Hospital of Anhui Medical University in China, a model of sciatic nerve defect was prepared by dissecting the sciatic nerve at the middle, left femur in female Sprague Dawley rats. The two ends of the nerve were encased in a silica gel tube. L5 dorsal root ganglia were harvested 7, 14 and 28 days post sciatic nerve injury for immunohistochemical staining. Results showed that substance P and calcitonin gene-related peptide expression increased significantly in dorsal root ganglion of rats with sciatic nerve injury. This increase peaked at 7 days, declined at 14 days, and reduced to normal levels by 28 days post injury. These findings published in the Neural Regeneration Research (Vol. 8, No. 33, 2013) suggest that these neuropeptides may possibly serve as an index for evaluating early peripheral nerve injury.


'/>"/>

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
Source:Eurekalert  

Page: 1

Related biology news :

1. A wrong molecular turn leads down the path to Type 2 diabetes
2. Uncovering first molecular missteps that drive neurons in pathway leading to Alzheimers disease
3. UI researcher studies evolution on the molecular level
4. Molecular interplay explains many immunodeficiencies
5. The Association for Molecular Pathology announces highlights of Phoenix meeting
6. Penn researchers identify molecular link between gut microbes and intestinal health
7. Singapore scientists expose molecular secrets of bile duct cancers from different countries
8. Molecular Velcro may lead to cost-effective alternatives to natural antibodies
9. Grafted limb cells acquire molecular fingerprint of new location, UCI study shows
10. Molecular biology: Designer of protein factories exposed
11. The molecular clock of the common buzzard
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Molecular markers used for assessment of early sciatic nerve injury
(Date:12/7/2016)... December 7, 2016 According to a new market research ... Tool (Facial Expression, Voice Recognition), Service, Application Area, End User, And Region - ... grow from USD 6.72 Billion in 2016 to USD 36.07 Billion by 2021, ... Continue Reading ... MarketsandMarkets Logo ...
(Date:12/7/2016)... Dec. 7, 2016   Avanade is helping ... One teams in history, exploit biometric data in order ... and maintain the competitive edge against their rivals after ... Avanade has worked with Williams during the ... biometric data (heart rate, breathing rate, temperature and peak ...
(Date:12/6/2016)... Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the "Company") today ... principal amount of its 1.414% senior unsecured notes due 2022 ... notes due 2026. The closing of the ... the satisfaction of customary closing conditions.  The notes will pay ... The Company intends to use the net proceeds from the ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... Jan. 18, 2017   Boston Biomedical , an ... to target cancer stemness pathways, will feature data from ... at the 2017 ASCO Gastrointestinal Cancers Symposium, held from ... Napabucasin is an orally-administered investigational agent ... i Cancer stem cells (CSCs) possess the property ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... for Clinical Ops Executives 2017 in its continued commitment to the advancement of ... makers to discuss current issues related to clinical trial planning and management. ...
(Date:1/18/2017)... ... January 18, 2017 , ... Announced in ... Innovation Institutes (MII). U.S. Secretary of Commerce Penny Pritzker has announced the award ... Department of Defense has announced the award of a new Advanced Regenerative Manufacturing ...
(Date:1/18/2017)... ... January 18, 2017 , ... DrugDev customers ... Clinical Ops Executives (Hyatt Regency Miami, January 24-26). DrugDev will join customers including ... issues such as trial performance metrics, patient enrollment diversity, protocol optimization, and global ...
Breaking Biology Technology: